thiotepa has been researched along with Recrudescence in 72 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (23.61) | 18.7374 |
| 1990's | 17 (23.61) | 18.2507 |
| 2000's | 15 (20.83) | 29.6817 |
| 2010's | 18 (25.00) | 24.3611 |
| 2020's | 5 (6.94) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, AK; Forlenza, CJ; Kernan, NA; Mauguen, A; Ramaswamy, K; Roshal, M; Shukla, N; Steinherz, PG; Sulis, ML; Trippett, T | 1 |
| Aljurf, M; Angelucci, E; Arat, M; Bernasconi, P; Giebel, S; Labopin, M; Mohty, M; Nagler, A; Pavlu, J; Peric, Z; Pioltelli, P; Rigacci, L; Risitano, A; Rovira, M; Saccardi, R; Savani, BN; Sica, S; Socié, G; Spyridonidis, A; Swoboda, R; Tischer, J; Van Gorkom, G; Vitek, A | 1 |
| Arpinati, M; Baronciani, D; Bernasconi, P; Bonifazi, F; Brunello, L; Bruno, B; Busca, A; Carella, AM; Carluccio, P; Casini, M; Chiusolo, P; Ciceri, F; Cilloni, D; Cupri, A; Di Grazia, C; Gheorghiu, A; Giglio, F; Girmenia, C; Grassi, A; Grillo, G; Iori, AP; Luppi, M; Martino, M; Masciulli, A; Musso, M; Nozzoli, C; Oldani, E; Onida, F; Palazzo, G; Parma, M; Patriarca, F; Pavoni, C; Peccatori, J; Picardi, A; Proia, A; Rambaldi, A; Sacchi, N; Santarone, S; Sorasio, R; Tringali, S; Vacca, A; Vallisa, D | 1 |
| Chen, J; Ding, Y; Hou, Y; Huang, X; Huang, Y; Li, X; Luo, C; Song, Q; Wu, G; Xu, S | 1 |
| Ahn, KW; Arshad, S; Awan, FT; Fang, X; Furqan, F; Hamadani, M; Kaur, M; Sauter, CS; Scordo, M | 1 |
| Aljurf, M; Arcese, W; Beelen, D; Beohou, E; Canaani, J; Cortelezzi, A; Eder, S; Finke, J; Giebel, S; Gurman, G; Labopin, M; Mohty, M; Nagler, A; Or, R; Passweg, J; Sanz, J; Socié, G; Stelljes, M | 1 |
| Avni, B; Grisariu, S; Nachmias, B; Or, R; Shapira, M; Sheth, V | 1 |
| Alessandrino, EP; Bacigalupo, A; Bonifazi, F; Bosi, A; Bregante, S; Bruno, B; Carella, AM; Fanin, R; Finazzi, MC; Mammoliti, S; Masciulli, A; Messina, G; Milone, G; Narni, F; Patriarca, F; Pavoni, C; Rambaldi, A; Russo, D | 1 |
| Frączkiewicz, J; Gajek, K; Kałwak, K; Mielcarek-Siedziuk, M; Raciborska, A; Rosa, M; Rybka, B; Ryczan-Krawczyk, R; Salamonowicz, M; Ślęzak, A; Ussowicz, M; Wawrzyniak-Dzierżek, E; Węcławek-Tompol, J | 1 |
| Andersson, BS; Bayraktar, UD; Boulad, F; Castro-Malaspina, HR; Champlin, RE; Chen, J; Chiattone, A; de Lima, M; Giralt, S; Jakubowski, AA; Kernan, NA; Maloy, M; O'Reilly, RJ; Papadopoulos, EB; Rondon, G; Saliba, RM | 1 |
| Baetschmann, G; Winkelmann, R | 1 |
| Kobos, R; Renaud, T; Shukla, N; Steinherz, LJ; Steinherz, PG | 1 |
| Angelucci, E; Baronciani, D; Culurgioni, F; Depau, C; Derudas, D; Latte, G; Palmas, A; Tandurella, I; Targhetta, C | 1 |
| Borders, EB; Cherry, MA; Herman, T; Holter, J; Selby, GB; Srour, SA | 1 |
| Arcese, W; Barba, P; Esquirol, A; Gayoso, J; Guidi, S; Martino, R; Montesinos, P; Moscardó, F; Parody, R; Picardi, A; Piñana, JL; Sanz, G; Sanz, J; Sanz, MA; Sierra, J; Solano, C; Terol, MJ | 1 |
| Bunjes, D; Eder, S; Finke, J; Kanz, L; Labopin, M; Messina, G; Mohty, M; Nagler, A; Olivieri, A; Rambaldi, A; Santarone, S | 1 |
| Evans, AT; Gooley, TA; McCune, JS; McDonald, GB; Ostrow, JD; Schoch, G | 1 |
| Kobos, R; Shukla, N; Steinherz, L; Steinherz, PG | 1 |
| Baek, HJ; Kim, HS; Lim, DH; Park, ES; Park, HJ; Park, KD; Sung, KW; Won, SC | 1 |
| Bertz, H; Christopoulos, P; Finke, J; Ihorst, G; Marks, R; Wäsch, R | 1 |
| Finke, J; Fritsch, K; Illerhaus, G; Kasenda, B; Schorb, E | 1 |
| Bouabdallah, K; Choquet, S; Damaj, G; Delgadillo, D; Dupriez, B; Fourme, E; Ghesquières, H; Gonzalez, A; Hoang-Xuan, K; Houillier, C; Leblond, V; Soussain, C; Taillandier, L; Vargaftig, J | 1 |
| Bertz, H; Christopoulos, P; Finke, J; Marks, R; Schmoor, C; Wäsch, R; Waterhouse, M | 1 |
| Chaudhry, A; Forsyth, P; Russell, J; Stewart, DA; Zia, MI | 1 |
| Anderson Penno, E; Braun, DA; Gimbel, HV; Hamilton, WK; Kamal, A | 1 |
| MEACHAM, CT | 1 |
| Kolb, EA; Steinherz, PG | 1 |
| Hoang-Xuan, K; Levy, V; Soussain, C | 1 |
| Beall, CL; Bunner, P; Devetten, MP; Ericson, SG; Lynch, JP; Qazilbash, MH; Weisenborn, R | 1 |
| Ahmed, T; Hoang, A; Kancherla, R; Liu, D; Qureshi, Z; Seiter, K; Waheed, F | 1 |
| Alessandrino, EP; Bernasconi, P; Caldera, D; Colombo, AA; Lazzarino, M; Malcovati, L; Montanari, F; Troletti, D; Vanelli, L; Varettoni, M | 1 |
| Joselson, GA; Muller, P | 1 |
| Allwinn, R; Beske, F; Klingebiel, T; Kriener, S; Lehrnbecher, T; Modrow, S; Schmidt, H; Schwabe, D; Sörensen, J | 1 |
| Bertz, H; Finke, J; Grüllich, C; Müller, CI; Spyridonidis, A | 1 |
| Arkenau, HT; Ethell, M; Hiwarkar, P; Morgan, G; Potter, M; Treleaven, J | 1 |
| Blondel, P; Garron, J; Gourcuff, A; Perruchot, PJ; Tassy, A | 1 |
| Barishak, YR; Monselise, M; Politi, F; Schwartz, M | 1 |
| Diener, K; Dimopoulos, M; Giralt, S; Hagemeister, F; Ippoliti, C; Khouri, I; Mehra, R; Nath, R; Przepiorka, D; Samuels, B | 1 |
| Ghalie, R; Hartsell, WF; Kaizer, H; Shah, AB | 1 |
| Andersson, BS; Bellare, N; Gajewski, JL; Giralt, SA; Khouri, IF; McCarthy, P; Mehra, R; Nath, R; Przepiorka, D; van Besien, KW | 1 |
| Ahmed, T; Akhtar, T; Chun, H; Feldman, E; Grima, K; Helson, L; Lake, D; Mittelman, A; Puccio, C; Seiter, K | 1 |
| Ahmed, T; Akhtar, T; Ascensao, J; Beer, M; Coleman, M; Cook, P; Feldman, EJ; Goldberg, R; Helson, L; Kancherla, R; Lake, DE; Mittelman, A; Preti, RA; Seiter, K | 1 |
| Ascensao, JL; Fontelonga, A; Hall, S; Kelly, AJ; MacKintosh, FR; Monroe, P; Ruthven, A; Shaft, D; Wilson, GS | 1 |
| Amin, K; Anderlini, P; Andersson, B; Cabanillas, F; Champlin, R; Gajewski, J; Giralt, S; Hester, J; Khouri, I; Korbling, M; Mehra, R; Mirza, N; Przepiorka, D; Pugh, WC; Seong, D; Thall, P; van Besien, K | 1 |
| Burt, ME; Ginsberg, RJ; Girardi, LN | 1 |
| Bitran, JD; Grad, G; Grinblatt, DL; Laport, GF; Williams, SF | 1 |
| Jürgens, H; Kleta, R; Wagner, A | 1 |
| Kayembe, L; Ngoy, D | 1 |
| Antman, KH; Bagiella, E; Balmaceda, C; Bruce, J; De LaPaz, R; Fetell, M; Garrett, TJ; Garvin, JH; Hawks, R; Hesdorffer, CS; Isaacson, S; Papadopoulos, KP; Savage, DG; Sisti, M; Vahdat, LT | 1 |
| Ribe, D; Tassy, A | 1 |
| Blume, KG; Chao, NJ; Hu, WW; Johnston, LJ; Long, GD; Negrin, RS; Stockerl-Goldstein, KE | 1 |
| Beyer, J; Rick, O; Siegert, W | 1 |
| Armstrong, RD; Bayer, R; Chen, B; Douville, J; Franklin, W; Hsi, E; Malhotra, D; Mandalam, R; Muller, T; Oldenberg, D; Shpall, E; Smith, A; Stiff, P | 1 |
| Ghosh, D; Lin, DY | 1 |
| Maisch, B; Ristić, AD; Seferovic, PM | 1 |
| Beck, JD; Greil, J; Hertzberg, H; Kremens, B; Velten, I | 1 |
| Benedetti, F; Bordignon, C; Bregni, M; Ciceri, F; Corradini, P; Dodero, A; Falda, M; Gianni, AM; Ladetto, M; Lucesole, M; Olivieri, A; Pileri, A; Rambaldi, A; Sajeva, MR; Tarella, C; Tresoldi, M; Voena, C; Zallio, F | 1 |
| Andersson, L; Edsmyr, F | 1 |
| Haik, GM; Haik, KG; Olander, K | 1 |
| Pavone-Macaluso, M | 1 |
| Harrower, HW; Higgins, GA; Keehn, RJ; Mendeloff, GL; Serlin, O | 1 |
| Ehrlich, D | 1 |
| Farrow, GM; Malek, RS; O'Dea, MJ | 1 |
| Dobrzecki, W; Kaczmarek, A | 1 |
| Daly, JJ; Heaney, JA; Heney, NM; Nieh, PT; Prout, GR | 1 |
| Emanuél', NM; Konovalova, NP; Parkanskiĭ, MI | 1 |
| Jacobo, EC; Schmidt, JD; Weinstein, SH | 1 |
| Hirst, LW; Sebban, A | 1 |
| Bitran, JD; Mick, R; Moormeier, J; Williams, SF | 1 |
| Bredin, HC; Dretler, SP | 1 |
| Asregadoo, ER | 1 |
| Swierzowa, J | 1 |
2 review(s) available for thiotepa and Recrudescence
| Article | Year |
|---|---|
Myeloablative conditioning regimens in adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation in complete remission: a systematic review and network meta-analysis.
Topics: Adult; Bayes Theorem; Busulfan; Cyclophosphamide; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Network Meta-Analysis; Recurrence; Retrospective Studies; Thiotepa; Transplantation Conditioning; Transplantation, Homologous | 2023 |
Management of pterygia: should thiotepa be used?
Topics: Animals; Humans; Pigmentation Disorders; Pterygium; Recurrence; Sunlight; Thiotepa | 1978 |
23 trial(s) available for thiotepa and Recrudescence
| Article | Year |
|---|---|
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01.
Topics: Busulfan; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Prospective Studies; Recurrence; Thiotepa; Transplantation Conditioning; Vidarabine | 2022 |
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group.
Topics: Adult; Blood Donors; Busulfan; Female; Follow-Up Studies; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Primary Myelofibrosis; Prognosis; Recurrence; Survival Analysis; Thiotepa; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2019 |
Feasibility and Safety of Treosulfan, Melphalan, and Thiotepa-Based Megachemotherapy with Autologous or Allogeneic Stem Cell Transplantation in Heavily Pretreated Children with Relapsed or Refractory Neuroblastoma.
Topics: Allografts; Antineoplastic Combined Chemotherapy Protocols; Autografts; Busulfan; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Male; Melphalan; Neuroblastoma; Recurrence; Stem Cell Transplantation; Survival Rate; Thiotepa | 2019 |
Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia.
Topics: Adenine Nucleotides; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Thiotepa; Topotecan; Vinblastine; Vinorelbine | 2014 |
Treosulfan-fludarabine-thiotepa conditioning before allogeneic haemopoietic stem cell transplantation for patients with advanced lympho-proliferative disease. A single centre study.
Topics: Adult; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Salvage Therapy; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Vidarabine; Young Adult | 2016 |
Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Busulfan; Chronic Disease; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Female; Graft Survival; Graft vs Host Disease; Herpesvirus 4, Human; Hodgkin Disease; Humans; Infectious Mononucleosis; Male; Middle Aged; Myeloablative Agonists; Recurrence; Survival Analysis; Thiotepa; Transplantation Conditioning; Vidarabine | 2016 |
Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT.
Topics: Adolescent; Adult; Aged; Allografts; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mucositis; Recurrence; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation Conditioning | 2017 |
Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Infant; Male; Prospective Studies; Recurrence; Rhabdoid Tumor; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous | 2012 |
Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma: a retrospective study of 79 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Cyclophosphamide; Disease-Free Survival; Eye Neoplasms; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Recurrence; Retrospective Studies; Salvage Therapy; Survival Rate; Thiotepa; Transplantation, Autologous | 2012 |
A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Deoxycytidine; Dexamethasone; Drug Administration Schedule; Female; Gemcitabine; Humans; Leukemia; Male; Recurrence; Thiotepa; Topotecan; Treatment Outcome; Vinblastine; Vinorelbine | 2003 |
Thiotepa and fractionated TBI conditioning prior to allogeneic stem cell transplantation for advanced hematologic malignancies: a phase II single institution trial.
Topics: Acute Disease; Adult; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Radiation Dosage; Recurrence; Retrospective Studies; Survival Analysis; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2004 |
Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Female; Graft Survival; Hematologic Neoplasms; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Survival Analysis; Thiotepa; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2004 |
A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Rate; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Failure; Vidarabine | 2008 |
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Heart Diseases; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Recurrence; Remission Induction; Thiotepa; Transplantation, Autologous; Treatment Outcome | 1995 |
Patterns of failure following bone marrow transplantation for metastatic breast cancer: the role of consolidative local therapy.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Recurrence; Survival Rate; Thiotepa; Time Factors; Transplantation, Autologous; Treatment Failure | 1995 |
Single and double autotransplants for relapsing/refractory Hodgkin's disease: results of two consecutive trials.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Life Tables; Male; Middle Aged; Mitoxantrone; Recurrence; Remission Induction; Retreatment; Salvage Therapy; Survival Analysis; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vinblastine | 1997 |
A novel high-dose chemotherapy protocol with autologous hematopoietic rescue in patients with metastatic breast cancer or recurrent non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Recurrence; Thiotepa; Transplantation, Autologous | 1997 |
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
Topics: Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Disease-Free Survival; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Prospective Studies; Recurrence; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1997 |
High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Methotrexate; Middle Aged; Mitoxantrone; Recurrence; Survival Rate; Thiotepa; Time Factors; Transplantation, Autologous; Vincristine | 1998 |
[A comparative study of thio-tepa and mitomycin C in the treatment of pterygium. Preliminary results].
Topics: Administration, Topical; Adult; Aged; Alkylating Agents; Conjunctiva; Cost-Benefit Analysis; Drug Costs; Evaluation Studies as Topic; Female; Follow-Up Studies; Headache; Humans; Iritis; Male; Middle Aged; Mitomycin; Nucleic Acid Synthesis Inhibitors; Prospective Studies; Pterygium; Pupil; Recurrence; Safety; Single-Blind Method; Tears; Thiotepa | 1998 |
A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Paclitaxel; Recurrence; Thiotepa; Transplantation, Autologous; Treatment Outcome | 1999 |
Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer.
Topics: Adult; Antigens, CD34; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Cell Culture Techniques; Cell Division; Cyclophosphamide; Female; Humans; Middle Aged; Recurrence; Thiotepa; Time Factors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2000 |
Factors related to survival following resection for gastric carcinoma: analysis of 903 cases.
Topics: Adult; Aged; Clinical Trials as Topic; Floxuridine; Humans; Male; Middle Aged; Prognosis; Recurrence; Remission, Spontaneous; Statistics as Topic; Stomach Neoplasms; Thiotepa; Time Factors | 1977 |
47 other study(ies) available for thiotepa and Recrudescence
| Article | Year |
|---|---|
Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Child; Clofarabine; Humans; Leukemia, Myeloid, Acute; Recurrence; Thiotepa; Topotecan; Vinorelbine; Young Adult | 2022 |
Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia W
Topics: Adult; Busulfan; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Thiotepa; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2022 |
Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiotepa/carmustine conditioning.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Recurrence; Retrospective Studies; Thiotepa; Transplantation, Autologous | 2023 |
Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society f
Topics: Adolescent; Adult; Cyclophosphamide; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multivariate Analysis; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Survival Rate; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult | 2017 |
Augmented myeloablative conditioning with thiotepa in acute myeloid leukemia - improved outcomes with similar toxicity.
Topics: Adolescent; Adult; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Myeloablative Agonists; Recurrence; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult | 2019 |
Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission.
Topics: Adult; Aged; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphocyte Depletion; Male; Melphalan; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; T-Lymphocytes; Thiotepa; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2013 |
Modeling zero-inflated count data when exposure varies: With an application to tumor counts.
Topics: Biometry; Follow-Up Studies; Humans; Models, Statistical; Poisson Distribution; Randomized Controlled Trials as Topic; Recurrence; Stochastic Processes; Thiotepa; Time Factors; Tumor Burden; Urinary Bladder Neoplasms | 2013 |
Role of topotecan, vinorelbine, thiotepa and gemcitabine chemotherapy in relapsed/refractory adult acute leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retreatment; Thiotepa; Topotecan; Treatment Outcome; Vinblastine; Vinorelbine | 2015 |
Mortality outcomes after busulfan-containing conditioning treatment and haemopoietic cell transplantation in patients with Gilbert's syndrome: a retrospective cohort study.
Topics: Adult; Bilirubin; Busulfan; Cohort Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Gilbert Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Recurrence; Retrospective Studies; Risk Factors; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Washington; Whole-Body Irradiation | 2016 |
Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia.
Topics: Adenine Nucleotides; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Thiotepa; Topotecan; Vinblastine; Vinorelbine | 2010 |
Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Carmustine; Central Nervous System; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Survival Analysis; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2012 |
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Lymphoma; Male; Middle Aged; Prognosis; Recurrence; Stem Cell Transplantation; Thiotepa | 2012 |
Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML.
Topics: Adult; Aged; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myeloablative Agonists; Recurrence; Retrospective Studies; Stem Cell Transplantation; Thiotepa; Time Factors; Transplantation Conditioning; Vidarabine | 2013 |
Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2002 |
Topical thiotepa treatment for recurrent corneal haze after photorefractive keratectomy.
Topics: Administration, Topical; Adult; Antineoplastic Agents, Alkylating; Astigmatism; Corneal Opacity; Humans; Lasers, Excimer; Male; Middle Aged; Myopia; Ophthalmic Solutions; Photorefractive Keratectomy; Postoperative Complications; Recurrence; Thiotepa; Visual Acuity | 2003 |
PREVENTION ON RECURRENCE OF PTERYGIUM.
Topics: Biomedical Research; Humans; Neoplasms; Preventive Medicine; Pterygium; Recurrence; Thiotepa | 1965 |
[Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Eye Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, T-Cell; Middle Aged; Prognosis; Recurrence; Thiotepa | 2004 |
High dose chemotherapy with thiotepa, mitoxantrone and carboplatin (TMJ) followed by autologous stem cell support in 100 consecutive lymphoma patients in a single centre: analysis of efficacy, toxicity and prognostic factors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Carboplatin; Disease-Free Survival; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Multivariate Analysis; Prognosis; Recurrence; Remission Induction; Stem Cell Transplantation; Thiotepa; Time Factors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2004 |
Incidence of pterygium recurrence in patients treated with thio-tepa.
Topics: Antineoplastic Agents, Alkylating; Follow-Up Studies; Humans; Incidence; Pterygium; Recurrence; Thiotepa; United States | 1966 |
Parvovirus B19 pneumonia in a child undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Antineoplastic Agents; Combined Modality Therapy; Erythema Infectiosum; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Male; Parvovirus B19, Human; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiography, Thoracic; Recurrence; Thiotepa; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2007 |
The feasibility of using topotecan, vinorelbine, thiotepa and gemcitabine (TVTG) in adult patients with relapsed/refractory acute lymphoblastic leukaemia/lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Feasibility Studies; Female; Gemcitabine; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Thiotepa; Topotecan; Vinblastine; Vinorelbine | 2008 |
[Thio-tepa eyedrops against recurrent pterygium and neovascularization of the cornea].
Topics: Cornea; Humans; Neovascularization, Pathologic; Ophthalmic Solutions; Postoperative Care; Pterygium; Recurrence; Thiotepa | 1984 |
Pterygium and beta irradiation.
Topics: Dexamethasone; Humans; Postoperative Complications; Pterygium; Recurrence; Thiotepa | 1984 |
Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Platelet Transfusion; Recurrence; Remission Induction; Survival Analysis; Thiotepa; Transplantation, Homologous; Whole-Body Irradiation | 1995 |
Factors influencing prognosis after dose-intensive therapy for recurrent or refractory Hodgkin's disease. Results of sequential trials: a case for treating patients with resistant disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carmustine; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Mitoxantrone; Prognosis; Recurrence; Survival Rate; Thiotepa; Treatment Outcome; Vinblastine | 1995 |
Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Drainage; Endoscopy; Female; Humans; Male; Middle Aged; Neoplasms; Paracentesis; Pericardial Effusion; Pericardial Window Techniques; Pericardiectomy; Recurrence; Retrospective Studies; Sclerotherapy; Survival Rate; Thiotepa; Thoracoscopy | 1997 |
Recurrence of SIADH after a high-dose regimen of thiotepa, carboplatin, and etoposide phosphate.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Inappropriate ADH Syndrome; Infant; Recurrence; Thiotepa | 1998 |
High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Recurrence; Thiotepa; Transplantation, Autologous; Treatment Outcome | 1998 |
[Thiotepa eyedrops for prevention of pterygium recurrence: 18 years of use].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Follow-Up Studies; Humans; Middle Aged; Ophthalmic Solutions; Pterygium; Recurrence; Thiotepa; Time Factors | 1999 |
High-dose salvage chemotherapy. Germ-cell tumor treatment results in Germany.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Germany; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Male; Prognosis; Recurrence; Salvage Therapy; Survival Rate; Testicular Neoplasms; Thiotepa | 1999 |
Nonparametric analysis of recurrent events and death.
Topics: Antineoplastic Agents, Alkylating; Biometry; Cause of Death; Controlled Clinical Trials as Topic; Humans; Models, Statistical; Placebos; Recurrence; Statistics, Nonparametric; Survival Rate; Thiotepa; Urinary Bladder Neoplasms | 2000 |
New directions in diagnosis and treatment of pericardial disease. A project of the Taskforce on Pericardial Disease of the World Heart Federation.
Topics: Chronic Disease; Cisplatin; Clinical Trials as Topic; Colchicine; Heart Diseases; Heart Neoplasms; Humans; Medical Laboratory Science; Pericardial Effusion; Pericarditis; Pericardium; Recurrence; Thiotepa; Triamcinolone | 2000 |
Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation.
Topics: Antigens, CD34; Antineoplastic Agents; Bone Marrow Neoplasms; Bone Neoplasms; Carboplatin; Child; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Recurrence; Remission Induction; Retinoblastoma; Thiotepa; Transplantation, Autologous; Vincristine | 2001 |
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.
Topics: Adult; Aged; Anemia, Refractory, with Excess of Blasts; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Transfusion; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Polymerase Chain Reaction; Recurrence; Remission Induction; Survival Rate; Thiotepa; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Chemotherapy in bladder carcinoma.
Topics: Antineoplastic Agents; Bleomycin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Recurrence; Thiotepa; Urinary Bladder Neoplasms; Vincristine | 1978 |
Chemotherapy of bladder tumours.
Topics: Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Papillary; Humans; Neoplasm Metastasis; Papilloma; Recurrence; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1978 |
The management of pterygium.
Topics: Administration, Topical; Anti-Inflammatory Agents; Glucocorticoids; Humans; Postoperative Complications; Pterygium; Radiotherapy; Recurrence; Strontium Radioisotopes; Thiotepa | 1977 |
Malacoplakia of the urinary tract: challenges and frustations with 10 cases.
Topics: Adult; Aged; Ammonium Chloride; Anti-Bacterial Agents; Electrocoagulation; Female; Humans; Liver Diseases; Malacoplakia; Male; Methenamine; Middle Aged; Recurrence; Sulfonamides; Thiotepa; Ureteral Diseases; Urinary Bladder Diseases; Urologic Diseases | 1977 |
The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.
Topics: Humans; Recurrence; Thiotepa; Urinary Bladder Neoplasms | 1977 |
The effect of intravesical thio-tepa on normal and tumor urothelium.
Topics: Carcinoma, Transitional Cell; Epithelium; Humans; Recurrence; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1978 |
[Effect of different regimens of chemotherapy and x-ray irradiation on the kinetics of experimental tumor growth].
Topics: Animals; Carcinoma; Carcinoma 256, Walker; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Kinetics; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Recurrence; Remission, Spontaneous; Thiotepa; Time Factors; X-Ray Therapy | 1975 |
Vesicoureteral reflux in recurrent carcinoma of the bladder--implications for treatment and prognosis.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Female; Humans; Male; Middle Aged; Prognosis; Recurrence; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms; Urography; Vesico-Ureteral Reflux | 1976 |
Treatment of pterygia in Queensland.
Topics: Australia; Beta Particles; Data Collection; Humans; Postoperative Complications; Pterygium; Recurrence; Surveys and Questionnaires; Thiotepa | 1991 |
High-dose combination chemotherapy with thiotepa and autologous hematopoietic stem cell reinfusion in the treatment of patients with relapsed refractory lymphomas.
Topics: Adult; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Recurrence; Remission Induction; Survival Rate; Thiotepa | 1990 |
Managing carcinoma of the bladder.
Topics: Aged; Biopsy; Cystoscopy; Electrosurgery; Female; Hematuria; Humans; Male; Palliative Care; Recurrence; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms; Urinary Diversion; Urography | 1974 |
Surgery, thio-tepa, and corticosteroid in the treatment of pterygium.
Topics: Dexamethasone; Follow-Up Studies; Humans; Pigmentation Disorders; Pterygium; Recurrence; Sunlight; Thiotepa | 1972 |
Clinical evaluation of patients treated for rhabdomyosarcoma.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclophosphamide; Evaluation Studies as Topic; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Postoperative Care; Radiotherapy Dosage; Recurrence; Rhabdomyosarcoma; Thiotepa; Time Factors | 1972 |